SYNTARA LIMITED
Syntara is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. We are targeting extracellular matrix dysfunction with our world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. Our experienced team of scientists is focusing on correcting extracellular matrix (ECM) dysfunction. The ECM is a crucial component of the cell mi... croenvironment, both under normal as well as fibrotic and inflammatory-driven disease states. By developing effective inhibitors of the key enzymes involved, we can correct dysfunction within the ECM, leading to positive outcomes in a range of diseases with high unmet need, including haematological malignancies such as myelofibrosis and myelodysplastic syndrome, chronic fibrosis (including skin scarring, pulmonary fibrosis, chronic kidney disease, NASH and cardiac fibrosis) and neuroinflammation.
SYNTARA LIMITED
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Product Research
Founded:
1998-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.syntaratx.com.au
Total Employee:
11+
Status:
Active
Contact:
61 2 9454 7200
Total Funding:
1.39 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Analytics Font Awesome Mobile Non Scaleable Content Google Universal Analytics Cloudflare JS
Similar Organizations
ChoiPharm
ChoiPharm is a high-tech enterprise specializing in drug research and development.
Covance
Covance is a global contract research organization and drug development services company.
DeepMatter Group
DeepMatter Group provides medical research and development services.
JP Laboratories
JP Laboratories is a product research and development company.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
STC Biologics
STC Biologics is a biotechnology company that offers biologics drug research and development services.
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
USUN BIO
USUN BIO is a drug research and development company.
Yidao Biotechnology
Yidao Biotechnology research and develops vaccines and biomedical products.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2010-01-12 | Topigen Pharmaceuticals | Topigen Pharmaceuticals acquired by Syntara Limited | N/A |
Official Site Inspections
http://www.syntaratx.com.au
- Host name: s04de.syd5.hostingplatform.net.au
- IP address: 43.250.142.16
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "Syntara Limited"
Syntara - A clinical-stage drug development company
Syntara is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. We are targeting extracellular matrix dysfunction with our world-leading expertise in amine oxidase chemistry and …See details»
Corporate Governance – Syntara - syntaratx.com.au
A clinical‐stage drug development company primarily focused on blood related cancers.See details»
Syntara Limited is a clinical-stage drug development …
Syntara Limited is a clinical-stage drug development company targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood …See details»
Syntara Limited Company Profile | Management and Employees …
[email protected]: Syntara Limited Top Competitors. Company Employees Revenue Top technologies; Active Biochemku. 19: $4.2 M: Immutep. 41: $8.7 M: Azafaros. 20: $5.7 M: …See details»
Syntara Limited (SNT.AX) Company Profile & Facts - Yahoo Finance
See the company profile for Syntara Limited (SNT.AX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Syntara - LinkedIn
Syntara | 3,208 followers on LinkedIn. Syntara (ASX:SNT) is an ASX-listed clinical stage drug developer for diseases linked to fibrosis and inflammation. | Syntara Limited (ASX:SNT) is a clinical stage drug development company targeting …See details»
Pharmaxis to undergo major company restructure and …
Oct 3, 2023 Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) — soon to be renamed Syntara — has announced a major company restructure to refocus on developing drugs to treat blood-related cancers. The restructure ...See details»
Syntara Limited (ASX: SNT) Company Profile & Overview - Stock …
Oct 22, 2024 Syntara Limited operates as a clinical-stage drug development company that focuses on blood-related cancers in Australia. The company’s lead product candidate is …See details»
Syntara Announces Two-Tranche Placement to Raise A$10m
Dec 19, 2023 [email protected] CONTACT: Syntara Media: Felicity Moffatt: +61 418 677 701 [email protected] ... [email protected] JOIN THE …See details»
Syntara Limited - Crunchbase Company Profile
Syntara is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. We are targeting extracellular matrix dysfunction with our world-leading expertise in amine oxidase chemistry and …See details»
Syntara Limited - Overview, News & Similar companies - ZoomInfo
Syntara Limited contact info: Phone number: +61 294547200 Website: www.syntaratx.com.au What does Syntara Limited do? Syntara Ltd is a company that operates in the Religious …See details»
Investor Presentation - Syntara Limited (ASX:SNT) - Listcorp.
Mar 6, 2024 • SNT-5505 phase 2a myelofibrosis study combination study reports safety and efficacy data target ASH H2 2024 Q4 2023 H1 2024 Gary Phillips Chief Executive Officer …See details»
Syntara Ltd (ASX:SNT) Share Price - Market Index
Snapshot. Syntara Limited (SNT, formerly Pharmaxis Ltd) is a clinical stage drug development company with a focus on blood-related cancers. The company's drug discovery engine is …See details»
Contact - Syntara
[email protected]. Investor/Media Relations Matthew Wright (NWR Communications) +61 451 896 420 [email protected]. Partner and …See details»
Shareholders - Syntara
Name: Number of Shares % Total ‘000 1: HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED: 217,661,788: 18.2% 2: D AND A INCOME LIMITED: 187,554,114See details»
Syntara (ASX:SNT) - Stock Price, News & Analysis - Simply Wall St
5 days ago syntaratx.com.au Syntara Limited operates as a clinical-stage drug development company that focuses on blood-related cancers in Australia. The company’s lead product …See details»
SNT: Syntara Ltd Stock Price Quote - ASE - Bloomberg
Stock analysis for Syntara Ltd (SNT:ASE) including stock price, stock chart, company news, key statistics, fundamentals and company profile.See details»
Syntara Ltd (asx:SNT) Share Price - Morningstar
Learn about asx:SNT with our data and independent analysis including share price, star rating, valuation, dividends, and financials.See details»
People - Syntara
Dr Simon Green. Non-Executive Director. Experienced senior global pharma executive with 30 years’ of experience in the biotechnology industry. Actively involved in CSL’s global expansion …See details»
News - Syntara
Syntara has announced the first patient has been dosed in its randomised double-blind placebo controlled Phase 2 study of the Syntara drug discovery PXS-4728 studying patients with …See details»